Hematuria epidemiology and demographics: Difference between revisions
(→Sex) |
|||
| Line 3: | Line 3: | ||
{{SCC}} {{AE}}{{VSKP}} | {{SCC}} {{AE}}{{VSKP}} | ||
==Overview== | ==Overview== | ||
Asymptomatic hematuria is common in clinical practice, with a prevalence ranging from 0.18% to 38.7%.<ref name="pmid23312369">Loo RK, Lieberman SF, Slezak JM, Landa HM, Mariani AJ, Nicolaisen G et al. (2013) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=23312369 Stratifying risk of urinary tract malignant tumors in patients with asymptomatic microscopic hematuria.] ''Mayo Clin Proc'' 88 (2):129-38. [http://dx.doi.org/10.1016/j.mayocp.2012.10.004 DOI:10.1016/j.mayocp.2012.10.004] PMID: [https://pubmed.gov/23312369 23312369]</ref> Transient microscopic hematuria may occur in 6% to 39% of the population studied, but persistent microscopic hematuria in 3 or more consecutive urinalyses occurs less often, and is seen in 0.5% to 2% of the population under study | Asymptomatic hematuria is common in clinical practice, with a prevalence ranging from 0.18% to 38.7%.<ref name="pmid23312369">Loo RK, Lieberman SF, Slezak JM, Landa HM, Mariani AJ, Nicolaisen G et al. (2013) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=23312369 Stratifying risk of urinary tract malignant tumors in patients with asymptomatic microscopic hematuria.] ''Mayo Clin Proc'' 88 (2):129-38. [http://dx.doi.org/10.1016/j.mayocp.2012.10.004 DOI:10.1016/j.mayocp.2012.10.004] PMID: [https://pubmed.gov/23312369 23312369]</ref> Transient microscopic hematuria may occur in 6% to 39% of the population studied, but persistent microscopic hematuria in 3 or more consecutive urinalyses occurs less often, and is seen in 0.5% to 2% of the population under study. In the prevalence of underlying urinary tract disease, there is no clear difference between patients with transient microscopic hematuria and those with persistent microscopic hematuria.<ref>{{cite book | last = Rew | first = Karl | title = Primary care urology | publisher = Saunders | location = Philadelphia, Pa. London | year = 2010 | isbn = 978-1437724899 }}</ref> | ||
== Epidemiology and Demographics == | == Epidemiology and Demographics == | ||
Revision as of 04:17, 30 January 2017
|
Hematuria Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hematuria epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Hematuria epidemiology and demographics |
|
Risk calculators and risk factors for Hematuria epidemiology and demographics |
Steven C. Campbell, M.D., Ph.D. Associate Editor(s)-in-Chief: Venkata Sivakrishna Kumar Pulivarthi M.B.B.S [1]
Overview
Asymptomatic hematuria is common in clinical practice, with a prevalence ranging from 0.18% to 38.7%.[1] Transient microscopic hematuria may occur in 6% to 39% of the population studied, but persistent microscopic hematuria in 3 or more consecutive urinalyses occurs less often, and is seen in 0.5% to 2% of the population under study. In the prevalence of underlying urinary tract disease, there is no clear difference between patients with transient microscopic hematuria and those with persistent microscopic hematuria.[2]
Epidemiology and Demographics
Prevalence
Microscopic hematuria is quite common, with a prevalence of approximately 6.5% of adults, varying according to the characteristics of the population.[3] The prevalence of microscopic hematuria ranges from 1-20% depending on the population studied and also varies with on age, gender, frequency of testing, threshold used to define MH and presence of risk factors such as smoking.[3]
Age
Young patients are more likely to have intrinsic renal pathology (i.e. glomerulonephritis whereas malignancy is more common in the elderly).[4]
Gender
Malignancy of the bladder and kidney is at least twice as common in males than in females. Women are more commonly affected by urinary tract infections.
References
- ↑ Loo RK, Lieberman SF, Slezak JM, Landa HM, Mariani AJ, Nicolaisen G et al. (2013) Stratifying risk of urinary tract malignant tumors in patients with asymptomatic microscopic hematuria. Mayo Clin Proc 88 (2):129-38. DOI:10.1016/j.mayocp.2012.10.004 PMID: 23312369
- ↑ Rew, Karl (2010). Primary care urology. Philadelphia, Pa. London: Saunders. ISBN 978-1437724899.
- ↑ 3.0 3.1 Davis R, Jones JS, Barocas DA, Castle EP, Lang EK, Leveillee RJ et al. (2012) Diagnosis, evaluation and follow-up of asymptomatic microhematuria (AMH) in adults: AUA guideline. J Urol 188 (6 Suppl):2473-81. DOI:10.1016/j.juro.2012.09.078 PMID: 23098784
- ↑ Rew, Karl (2010). Primary care urology. Philadelphia, Pa. London: Saunders. ISBN 978-1437724899.